Aurinia Pharmaceuticals Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Aurinia Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2023.
  • Aurinia Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $14.4M.
  • Aurinia Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$22.6M, a 70.8% increase year-over-year.
  • Aurinia Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$78M, a 27.9% increase from 2022.
  • Aurinia Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$108M, a 40.2% increase from 2021.
  • Aurinia Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$181M, a 76.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$78M +$30.2M +27.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 -$108M +$72.8M +40.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 -$181M -$78.3M -76.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 -$103M -$14.3M -16.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$88.4M -$35.3M -66.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$53.1M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.